Cardiovascular disease and COPD: dangerous liaisons?

Klaus F. Rabe, John R. Hurst, Samy Suissa

Source: Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Klaus F. Rabe, John R. Hurst, Samy Suissa. Cardiovascular disease and COPD: dangerous liaisons?. Eur Respir Rev, 27 (149) 180057; 10.1183/16000617.0057-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cardiovascular disease in COPD
Source: Eur Respir Monogr 2020; 88: 47-65
Year: 2020


COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003

Caring for patients with early COPD: How hazardous is to family carers' psychological health?
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Smoking cessation: key for both COPD and cardiovascular disease, but how to manage it?
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017


Smoking and COPD: what really are the risks?
Source: Eur Respir J 2006 Oct 01;28(4):883-884
Year: 2006


Asthma in the elderly: a different disease?
Source: Breathe 2016; 12: 18-28
Year: 2016



Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality?
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


Pulmonary hypertension and chronic lung disease: where are we headed?
Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019
Year: 2019



Pulmonary hypertension in the elderly: a different disease?
Source: Breathe 2016; 12: 43-49
Year: 2016


Risk factors of pulmonary NTM disease in COPD: how bad are glucocorticoids?
Source: International Congress 2014 – The rise in non-tuberculous mycobacteria (NTM) pulmonary diseases
Year: 2014



Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?
Source: Eur Respir J 2015; 46: 846-849
Year: 2015


The European IPF Network: towards better care for a dreadful disease
Source: Eur Respir J 2011; 37: 747-748
Year: 2011


Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction?
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Repeat pulmonary rehabilitation programmes: Are they beneficial in COPD?
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 1
Year: 2014


Are COPD and cardiovascular disease fundamentally intertwined?
Source: Eur Respir J 2016; 47:1307-1309
Year: 2016


Cardiovascular comorbidity in COPD: Tip of iceberg
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014